Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

January 19, 2024

https://www.globenewswire.com/news-release/2023/11/30/2788538/0/en/Belite-Bio-to-Participate-in-the-Benchmark-Company-s-Upcoming-Discovery-One-on-One-Investor-Conference.html

SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will be participating at the Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference to be held Thursday, December 7, 2023, at the New York Athletic Club in New York City.

Read more at globenewswire.com

Related news for (BLTE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.